Fast, Ratiometric FRET from Quantum Dot Conjugated Stabilized Single Chain Variable Fragments for Quantitative Botulinum Neurotoxin Sensing

Nano Letters

Volumn 15, Issue 10, 2015, Pages 7161-7167

  Lee, Joonseok ^a   Brennan, Melissa B ^a   Wilton, Rosemarie ^a   Rowland, Clare E ^a,b   Rozhkova, Elena A ^a   Forrester, Sara ^a   Hannah, Daniel C ^b   Carlson, Julia ^c   Shevchenko, Elena V ^a   Schabacker, Daniel S ^a   Schaller, Richard D ^a,b  

^a ARGONNE NATIONAL LABORATORY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

botulinum neurotoxin; FRET; microarray; protein sensor; quantum dot; scFv

Indexed keywords

ANTIBODIES; CHAINS; CHEMICAL DETECTION; CHROMOPHORES; ENERGY TRANSFER; FLUORESCENCE; MICROARRAYS; NANOCRYSTALS;

BOTULINUM NEUROTOXINS; DENATURATION TEMPERATURES; FRET; PROTEIN SENSOR; RATIOMETRIC FLUORESCENCE; SCFV; SINGLE CHAIN VARIABLE FRAGMENTS; STANDARD DETECTION SCHEME;

SEMICONDUCTOR QUANTUM DOTS;

BOTULINUM TOXIN; QUANTUM DOT; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

CHEMISTRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIMIT OF DETECTION; PROCEDURES; RADIOMETRY;

BOTULINUM TOXINS; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIMIT OF DETECTION; QUANTUM DOTS; RADIOMETRY; SINGLE-CHAIN ANTIBODIES;

EID: 84944348368     PISSN: 15306984     EISSN: 15306992     Source Type: Journal    
DOI: 10.1021/acs.nanolett.5b03442     Document Type: Article

References (29)

1. Cai, S.; Singh, B. R.; Sharma, S. Botulism Diagnostics: From Clinical Symptoms to in Vitro Assays Crit. Rev. Microbiol. 2007, 33, 109-125 10.1080/10408410701364562
2. Singh, A. K.; Stanker, L. H.; Sharma, S. Botulinum Neurotoxin: Where Are We with Detection Technologies? Crit. Rev. Microbiol. 2013, 39, 43-56 10.3109/1040841X.2012.691457
3. Čapek, P.; Dickerson, T. J. Sensing the Deadliest Toxin: Technologies for Botulinum Neurotoxin Detection Toxins 2010, 2, 24-53 10.3390/toxins2010024
4. Marks, J. D. Deciphering Antibody Properties That Lead to Potent Botulinum Neurotoxin Neutralization Mov. Disord. 2004, 19, S101-S108 10.1002/mds.20023
5. Eisele, K.-H.; Fink, K.; Vey, M.; Taylor, H. V. Studies on the Dissociation of Botulinum Neurotoxin Type a Complexes Toxicon 2011, 57, 555-565 10.1016/j.toxicon.2010.12.019
6. Scotcher, M. C.; Cheng, L. W.; Stanker, L. H. Detection of Botulinum Neurotoxin Serotype B at Sub Mouse Ld50 Levels by a Sandwich Immunoassay and Its Application to Toxin Detection in Milk PLoS One 2010, 5, e11047 10.1371/journal.pone.0011047
7. Ferreira, J.; Eliasberg, S.; Edmonds, P.; Harrison, M. Comparison of the Mouse Bioassay and Enzyme-Linked Immunosorbent Assay Procedures for the Detection of Type a Botulinal Toxin in Food J. Food Prot. 2004, 67, 203-206
8. Sapsford, K. E.; Granek, J.; Deschamps, J. R.; Boeneman, K.; Blanco-Canosa, J. B.; Dawson, P. E.; Susumu, K.; Stewart, M. H.; Medintz, I. L. Monitoring Botulinum Neurotoxin a Activity with Peptide-Functionalized Quantum Dot Resonance Energy Transfer Sensors ACS Nano 2011, 5, 2687-2699 10.1021/nn102997b
9. Ruge, D. R.; Dunning, F. M.; Piazza, T. M.; Molles, B. E.; Adler, M.; Zeytin, F. N.; Tucker, W. C. Detection of Six Serotypes of Botulinum Neurotoxin Using Fluorogenic Reporters Anal. Biochem. 2011, 411, 200-209 10.1016/j.ab.2011.01.002
10. Lillehoj, P. B.; Wei, F.; Ho, C.-M. A Self-Pumping Lab-on-a-Chip for Rapid Detection of Botulinum Toxin Lab Chip 2010, 10, 2265-2270 10.1039/c004885b
11. Lillehoj, P. B.; Huang, M.-C.; Truong, N.; Ho, C.-M. Rapid Electrochemical Detection on a Mobile Phone Lab Chip 2013, 13, 2950-2955 10.1039/c3lc50306b
12. Warner, M. G.; Grate, J. W.; Tyler, A.; Ozanich, R. M.; Miller, K. D.; Lou, J.; Marks, J. D.; Bruckner-Lea, C. J. Quantum Dot Immunoassays in Renewable Surface Column and 96-Well Plate Formats for the Fluorescence Detection of Botulinum Neurotoxin Using High-Affinity Antibodies Biosens. Bioelectron. 2009, 25, 179-184 10.1016/j.bios.2009.06.031
13. Förster, T. Energiewanderung Und Fluoreszenz Naturwissenschaften 1946, 33, 166-175 10.1007/BF00585226
14. Stryer, L. Fluorescence Energy Transfer as a Spectroscopic Ruler Annu. Rev. Biochem. 1978, 47, 819-846 10.1146/annurev.bi.47.070178.004131
15. Clapp, A. R.; Medintz, I. L.; Mattoussi, H. Förster Resonance Energy Transfer Investigations Using Quantum-Dot Fluorophores ChemPhysChem 2006, 7, 47-57 10.1002/cphc.200500217
16. Medintz, I. L.; Clapp, A. R.; Mattoussi, H.; Goldman, E. R.; Fisher, B.; Mauro, J. M. Self-Assembled Nanoscale Biosensors Based on Quantum Dot Fret Donors Nat. Mater. 2003, 2, 630-638 10.1038/nmat961
17. Medintz, I. L.; Uyeda, H. T.; Goldman, E. R.; Mattoussi, H. Quantum Dot Bioconjugates for Imaging, Labelling and Sensing Nat. Mater. 2005, 4, 435-446 10.1038/nmat1390
18. Resch-Genger, U.; Grabolle, M.; Cavaliere-Jaricot, S.; Nitschke, R.; Nann, T. Quantum Dots Versus Organic Dyes as Fluorescent Labels Nat. Methods 2008, 5, 763-775 10.1038/nmeth.1248
19. Wegner, K. D.; Jin, Z.; Lindén, S.; Jennings, T. L.; Hildebrandt, N. Quantum-Dot-Based Förster Resonance Energy Transfer Immunoassay for Sensitive Clinical Diagnostics of Low-Volume Serum Samples ACS Nano 2013, 7, 7411-7419 10.1021/nn403253y
20. Lacy, D. B.; Tepp, W.; Cohen, A. C.; DasGupta, B. R.; Stevens, R. C. Crystal Structure of Botulinum Neurotoxin Type a and Implications for Toxicity Nat. Struct. Biol. 1998, 5, 898-902 10.1038/2338
21. Amersdorfer, P.; Wong, C.; Chen, S.; Smith, T.; Deshpande, S.; Sheridan, R.; Finnern, R.; Marks, J. D. Molecular Characterization of Murine Humoral Immune Response to Botulinum Neurotoxin Type a Binding Domain as Assessed by Using Phage Antibody Libraries Infect. Immun. 1997, 65, 3743-52
22. Garcia-Rodriguez, C.; Levy, R.; Arndt, J. W.; Forsyth, C. M.; Razai, A.; Lou, J.; Geren, I.; Stevens, R. C.; Marks, J. D. Molecular Evolution of Antibody Cross-Reactivity for Two Subtypes of Type a Botulinum Neurotoxin Nat. Biotechnol. 2007, 25, 107-16 10.1038/nbt1269
23. Razai, A.; Garcia-Rodriguez, C.; Lou, J.; Geren, I. N.; Forsyth, C. M.; Robles, Y.; Tsai, R.; Smith, T. J.; Smith, L. A.; Siegel, R. W.; Feldhaus, M.; Marks, J. D. Molecular Evolution of Antibody Affinity for Sensitive Detection of Botulinum Neurotoxin Type A J. Mol. Biol. 2005, 351, 158-69 10.1016/j.jmb.2005.06.003
24. Mullaney, B.; Pallavicini, M.; Marks, J. Epitope Mapping of Neutralizing Botulinum Neurotoxin a Antibodies by Phage Display Infect. Immun. 2001, 69, 6511-6514 10.1128/IAI.69.10.6511-6514.2001
25. Baldwin, M. R.; Tepp, W. H.; Przedpelski, A.; Pier, C. L.; Bradshaw, M.; Johnson, E. A.; Barbieri, J. T. Subunit Vaccine against the Seven Serotypes of Botulism Infect. Immun. 2008, 76, 1314-1318 10.1128/IAI.01025-07
26. Chen, R.; Shi, J.; Cai, K.; Tu, W.; Hou, X.; Liu, H.; Xiao, L.; Wang, Q.; Tang, Y.; Wang, H. Improved Soluble Expression and Characterization of the Hc Domain of Clostridium botulinum Neurotoxin Serotype a in Escherichia Coli by Using a Pcr-Synthesized Gene and a Trx Co-Expression Strain Protein Expression Purif. 2010, 71, 79-84 10.1016/j.pep.2009.11.007
27. Clayton, M. A.; Clayton, J. M.; Brown, D. R.; Middlebrook, J. L. Protective Vaccination with a Recombinant Fragment of Clostridium Botulinum Neurotoxin Serotype a Expressed from a Synthetic Gene in Escherichia Coli Infect. Immun. 1995, 63, 2738-2742
28. Zhang, H.; Feng, G.; Guo, Y.; Zhou, D. Robust and Specific Ratiometric Biosensing Using a Copper-Free Clicked Quantum Dot-DNA Aptamer Sensor Nanoscale 2013, 5, 10307-10315 10.1039/c3nr02897f
29. Schabacker, D. S.; Stefanovska, I.; Gavin, I.; Pedrak, C.; Chandler, D. P. Protein Array Staining Methods for Undefined Protein Content, Manufacturing Quality Control, and Performance Validation Anal. Biochem. 2006, 359, 84-93 10.1016/j.ab.2006.08.035